Wireless & RF Regulatory Compliance for Medical Devices: FCC, RED, and Global Requirements
A comprehensive guide to wireless and RF regulatory compliance for connected medical devices — FCC equipment authorization, EU Radio Equipment Directive (RED), wireless coexistence testing, cybersecurity requirements, risk management, and global market access strategies.
Why Wireless Compliance Matters for Medical Devices
Wireless functionality has become standard in modern medical devices. From Bluetooth-connected glucose monitors and Wi-Fi-enabled patient monitors to cellular-linked infusion pumps and RFID-tracked surgical instruments, hundreds of pieces of medical equipment in hospitals now incorporate some form of wireless technology. But adding wireless capability to a medical device introduces a dual compliance burden: the device must satisfy both medical device regulations and radio/telecommunications regulations — and these two regulatory frameworks operate very differently across global markets.
The challenge is significant because medical and wireless regulatory bodies are usually separate. In the US, the FDA regulates medical devices while the FCC governs radio spectrum use. In the EU, the EU MDR governs devices while the Radio Equipment Directive (RED) governs wireless equipment. In many second- and third-tier markets, there is little to no coordination between medical and telecommunications regulators. Manufacturers must understand and navigate both frameworks simultaneously to bring connected medical devices to market.
The Dual Compliance Challenge
When wireless functionality is added to a medical device, it becomes subject to two distinct sets of requirements:
| Dimension | Medical Device Regulation | Wireless/RF Regulation |
|---|---|---|
| US | FDA (510(k), PMA, De Novo) | FCC Equipment Authorization |
| EU | EU MDR (CE marking) | Radio Equipment Directive (RED) |
| UK | UKCA marking (MHRA) | UK Radio Equipment Regulations |
| Canada | Health Canada (MDL) | ISED Certification |
| Japan | PMDA/MHLW | MIC Radio Law |
| Scope | Safety, efficacy, performance | Spectrum use, EMC, RF exposure |
| Assessment | Risk management, clinical evidence | RF testing, EMC, coexistence |
| Overlap | EMC, cybersecurity, risk management | EMC, RF safety, data protection |
The key insight: these are not independent processes. EMC testing feeds into both pathways. Cybersecurity requirements overlap. Risk management must address both medical and wireless failure modes. Treating them as separate silos leads to duplicated testing, delayed timelines, and regulatory gaps.
US Requirements: FDA and FCC
FDA Wireless Medical Device Policy
The FDA's guidance document "Radio Frequency Wireless Technology in Medical Devices" provides recommendations for developing and supporting safe and effective wireless medical devices. Key requirements include:
- Wireless coexistence — Devices must demonstrate they can coexist with other wireless devices in the intended use environment
- Quality of service (QoS) — The wireless link must provide adequate bandwidth, latency, and reliability for the medical function
- Security — Wireless data transmission must be protected against unauthorized access and modification
- Risk management — Wireless-specific risks must be identified and mitigated per ISO 14971
The FDA coordinates its policies with the FCC to provide manufacturers with predictability about regulatory requirements. However, FDA clearance does not constitute FCC authorization — they are separate processes that must both be completed.
FCC Equipment Authorization
The FCC oversees the use of the public radio frequency spectrum within which RF wireless technologies operate. Any device that contains an RF transmitter must be authorized under FCC rules (47 CFR Part 2, Subpart J) before it can be marketed in the United States.
FCC Authorization Pathways
| Pathway | Applicable To | Process | Typical Timeline |
|---|---|---|---|
| Supplier's Declaration of Conformity (SDoC) | Intentional radiators operating under Part 15 (Wi-Fi, Bluetooth, other unlicensed bands) | Self-declaration with testing at accredited lab | 2-4 weeks after testing |
| Certification | Higher-power devices, licensed-band devices, devices requiring more scrutiny | FCC-recognized Telecommunication Certification Body (TCB) reviews test data and grants certification | 4-8 weeks |
| Verification | Unintentional radiators (digital devices) | Self-verification of compliance | Included in EMC testing |
Most medical devices with Wi-Fi, Bluetooth, or other unlicensed wireless technologies use either SDoC or Certification, depending on the specific technology and power levels.
FCC-Designated Medical Frequency Bands
The FCC has designated specific frequency bands for medical device use:
| Service | Frequency Band(s) | Authorized Under | Typical Applications |
|---|---|---|---|
| MedRadio | 401-406 MHz | Part 95, Subpart I | Implantable devices, body-worn devices transmitting diagnostic/therapeutic data |
| Medical Micropower Networks (MMNs) | 413-419, 426-432, 438-444, 451-457 MHz | Part 95, Subpart I | Neuromuscular stimulation, restoring function to paralyzed limbs |
| Medical Body Area Networks (MBANs) | 2360-2400 MHz | Part 95, Subpart I | Body-worn sensor networks transmitting patient data to monitoring systems |
| Wireless Medical Telemetry Service (WMTS) | 608-614, 1395-1400, 1427-1432 MHz | Part 95, Subpart H | Hospital patient monitoring, short-range data transmission to central monitoring |
Medical devices may also operate under Part 15 unlicensed device rules in any frequency band available under that Part (including 2.4 GHz and 5 GHz for Wi-Fi/Bluetooth).
Key FCC Technical Requirements
- RF emissions limits — Must comply with specific emission limits for the frequency band of operation
- RF exposure — Devices used near the body must meet specific absorption rate (SAR) limits (1.6 W/kg for general population, averaged over 1 gram of tissue)
- Part 15 compliance — Devices operating under Part 15 rules must accept any interference from primary users of the frequency band
- FCC ID — Certified devices receive an FCC ID that must be displayed on the device and in marketing materials
Wireless Coexistence Testing
The FDA expects wireless medical devices to undergo coexistence testing to demonstrate they can operate safely alongside other wireless devices. The key standards are:
| Standard | Title | Scope |
|---|---|---|
| AAMI TIR 69 | Risk Management of RF Wireless Coexistence for Medical Devices | Risk management framework for wireless coexistence |
| ANSI C63.27 | Evaluation of Wireless Coexistence | Test methods for evaluating coexistence performance |
Coexistence testing simulates real-world wireless environments where multiple devices compete for the same spectrum. It evaluates whether the medical device can maintain its essential performance when subjected to interference from other wireless transmitters.
EU Requirements: EU MDR and RED
Radio Equipment Directive (RED)
The Radio Equipment Directive (2014/53/EU) governs the placing on the market of radio equipment in the EU. Any medical device that incorporates radio communication functionality must comply with both the EU MDR and the RED.
RED Essential Requirements
| Requirement | Description | Applicable Standard(s) |
|---|---|---|
| Article 3.1(a) | Safety (health and safety of persons, domestic animals, and property) | EN IEC 62368-1, EN 60950-1 |
| Article 3.1(b) | EMC (electromagnetic compatibility) | EN 301 489 series |
| Article 3.2 | Effective use of radio spectrum | ETSI EN 300 328 (Wi-Fi), ETSI EN 300 440 (Bluetooth), etc. |
| Article 3.3(d) | Network protection (cybersecurity) | ETSI EN 303 645 |
| Article 3.3(e) | Privacy protection | ETSI EN 303 645 |
| Article 3.3(f) | Fraud prevention | ETSI EN 303 645 |
RED Cybersecurity Requirements (Effective August 1, 2025)
Commission Delegated Regulation (EU) 2022/30 introduced additional essential requirements under RED Articles 3(3)(d), (e), and (f) for internet-connected radio devices. For products placed on the EU market from August 1, 2025 onwards, cybersecurity provisions must be designed in from the start — not added as an afterthought.
The requirements include:
- Secure update mechanisms for firmware and software
- Data protection controls for wireless data transmission
- Protection against fraud and unauthorized access
- Default passwords must not be trivially guessable
- Manufacturers must provide security updates for the expected product lifetime
For 2026 launches, this means connected medical devices must address RED cybersecurity compliance as part of both the medical device technical file and the RED conformity assessment.
RED Conformity Assessment
| Assessment Module | Description | When Used |
|---|---|---|
| Internal production control (Module A) | Self-assessment with technical documentation | For devices not requiring cybersecurity assessment |
| EU type examination (Module B) + Quality assurance (Module C/D/E) | Notified Body involvement | For devices with cybersecurity requirements |
| Full quality assurance (Module H) | Notified Body audits quality system | For manufacturers with comprehensive QMS |
CE Marking Under Both EU MDR and RED
A wireless medical device bears a single CE mark but must meet both regulatory frameworks:
- EU MDR conformity assessment — Conducted by a medical device Notified Body
- RED conformity assessment — May be self-declared or involve a separate radio equipment Notified Body
- Declaration of Conformity — A single DoC can cover both regulations, but the technical documentation must address all requirements from both
Important: CE marking is recognized indefinitely in Great Britain for EMC and radio equipment under the UK-EU agreement. UKCA marking remains a parallel, voluntary option.
UK Requirements
Post-Brexit, the UK operates its own regulatory framework:
- Medical devices: Regulated by MHRA under UKCA marking (CE marking accepted for medical devices)
- Radio equipment: UK Radio Equipment Regulations (RER) mirror the RED but are administered separately
- EMC: UK Electromagnetic Compatibility Regulations
Manufacturers must ensure compliance with both the UK medical device regulations and the UK radio equipment regulations. The technical requirements are substantially similar to the EU framework, but the administrative processes are separate.
Canada Requirements: ISED Certification
Innovation, Science and Economic Development Canada (ISED, formerly Industry Canada) regulates radio equipment in Canada. Key requirements:
- ISED certification — Radio equipment must be certified by ISED (equivalent to FCC certification)
- Technical standards — Similar to FCC requirements but with some Canadian-specific frequency allocations
- RSS standards — Radio Standards Specifications (RSS-247 for Wi-Fi, RSS-210 for Bluetooth, etc.)
- ICES standards — Interference-Causing Equipment Standards for EMC
- ISED ID — Certified devices receive an ISED certification number
Many manufacturers pursue simultaneous FCC and ISED certification to streamline North American market access. Testing can often be combined since the technical requirements overlap significantly.
In 2026, ISED introduced Issue 6 of RSS-310, updating the regulatory framework for licence-exempt Category II radio equipment. This reflects a broader regulatory trend toward harmonization, reduced administrative burden, and increased reliance on self-declaration for certain device categories.
Japan Requirements
Japan has a unique dual framework:
- Medical device approval — PMDA/MHLW under the Pharmaceuticals and Medical Devices Act (PMD Act)
- Radio equipment approval — Ministry of Internal Affairs and Communications (MIC) under the Radio Law
- Technical standards — JIS standards aligned with IEC, plus Japan-specific requirements
Japan requires all wireless devices to undergo MIC approval in addition to PMDA medical device approval. The PMDA does not evaluate radio compliance — it is a separate process.
Risk Management for Wireless Medical Devices
ISO 14971 risk management must address wireless-specific hazards that are unique to connected medical devices.
Wireless-Specific Hazard Categories
| Hazard Category | Example Scenarios | Risk Control Measures |
|---|---|---|
| RF interference | Medical device disrupted by other wireless equipment | EMC testing (IEC 60601-1-2), coexistence testing (ANSI C63.27) |
| Signal loss | Wireless link drops during critical monitoring | Redundant communication paths, wired backup, alarm on link loss |
| Data integrity | Corrupted data transmitted over wireless channel | Error detection/correction, message authentication |
| Unauthorized access | Attacker gains control of device via wireless interface | Authentication, encryption, access controls |
| Data privacy | Patient data intercepted over wireless link | End-to-end encryption, secure protocols |
| Bandwidth degradation | Network congestion causes delays in alarm transmission | Quality of service management, priority traffic handling |
| Coexistence failure | Multiple devices interfere with each other in clinical environment | Frequency coordination, channel management, coexistence testing |
AAMI TIR 69 Risk Management Framework
AAMI TIR 69 provides a structured approach to managing wireless coexistence risks:
- Identify wireless functions — Document all wireless technologies, frequencies, and intended use environments
- Characterize the wireless environment — Assess the expected RF environment at the point of care
- Define essential performance over wireless — What functions must the wireless link support?
- Conduct coexistence testing — Test per ANSI C63.27 to verify coexistence performance
- Evaluate residual risk — Determine if remaining wireless risks are acceptable
- Implement risk controls — Engineering controls, labeling, and user instructions
Cybersecurity Integration
Wireless medical devices face a convergence of three cybersecurity frameworks:
| Framework | Jurisdiction | Key Requirements |
|---|---|---|
| FDA Cybersecurity Guidance (2023) | US | Premarket cybersecurity documentation, SBOM, security testing |
| RED Articles 3.3(d)/(e)/(f) | EU | Cybersecurity, privacy, fraud prevention for connected devices |
| EU Cyber Resilience Act | EU | Product lifecycle cybersecurity requirements (applicable from 2027) |
FDA Cybersecurity Requirements for Wireless Devices
The FDA's 2023 cybersecurity guidance requires manufacturers to demonstrate that their devices are "sufficiently resilient to cybersecurity threats." For wireless devices specifically:
- Security architecture — Document the wireless security architecture including authentication, encryption, and key management
- Software Bill of Materials (SBOM) — Provide an SBOM that includes all wireless protocol stacks and firmware components
- Security testing — Conduct penetration testing of the wireless interface
- Threat modeling — Include wireless-specific threat vectors in the threat model
- Security updates — Provide a plan for delivering security patches throughout the device lifecycle
Practical Compliance Strategy
Step 1: Identify All Wireless Technologies
Catalog every wireless technology in your device:
- Radio protocols (Wi-Fi, Bluetooth, BLE, Zigbee, cellular, NFC, RFID)
- Frequency bands of operation
- Transmit power levels
- Intended use environments (hospital, home, ambulance, public)
Step 2: Determine Applicable Regulations by Market
| Market | Medical Regulation | Wireless Regulation | Assessment Body |
|---|---|---|---|
| US | FDA 510(k)/PMA/De Novo | FCC Equipment Authorization | FDA + TCB |
| EU | EU MDR (CE marking) | RED (CE marking) | MD Notified Body + RED assessment |
| UK | UKCA (MHRA) | UK RER | UK Approved Body |
| Canada | Health Canada MDL | ISED Certification | Health Canada + ISED |
| Japan | PMDA approval | MIC Radio Law | PMDA + MIC |
| Australia | TGA inclusion | ACMA standards | TGA + ACMA |
Step 3: Plan Integrated Testing
Maximize efficiency by combining tests where possible:
| Test | Covers | Standards | Timing |
|---|---|---|---|
| EMC emissions & immunity | Both medical and RF requirements | IEC 60601-1-2, EN 301 489 | 4-8 weeks |
| RF specific tests | RF spectrum use | ETSI EN 300 328, ETSI EN 300 440, FCC Part 15 | 2-4 weeks |
| Wireless coexistence | Medical device risk management | ANSI C63.27, AAMI TIR 69 | 2-4 weeks |
| Cybersecurity | FDA guidance, RED Art 3.3 | IEC 62443, ETSI EN 303 645 | 4-8 weeks |
| RF exposure (SAR) | Human exposure limits | IEEE C95.1, IEC 62209 | 2-4 weeks |
Step 4: Prepare Technical Documentation
For each market, prepare documentation addressing both medical and wireless requirements:
- US: 510(k) submission with EMC data + FCC test reports and authorization
- EU: EU MDR technical file + RED technical documentation + DoC covering both
- Canada: MDL application with EMC data + ISED test reports and certification
Cost and Timeline Estimates
| Activity | Cost Range | Timeline |
|---|---|---|
| RF testing (FCC/ISED) | $8,000–$20,000 | 2-4 weeks |
| EMC testing (IEC 60601-1-2) | $15,000–$35,000 | 4-8 weeks |
| Wireless coexistence testing | $10,000–$25,000 | 2-4 weeks |
| Cybersecurity assessment | $15,000–$40,000 | 4-8 weeks |
| SAR testing (if body-worn) | $5,000–$15,000 | 2-4 weeks |
| FCC certification (TCB fees) | $3,000–$8,000 | 1-2 weeks |
| Total wireless compliance program | $56,000–$143,000 | 4-6 months |
Frequently Asked Questions
Can I use a pre-certified radio module to simplify compliance?
Yes, but with important caveats. Using a pre-certified radio module (one that has already received FCC ID, CE marking under RED, or ISED certification) simplifies the wireless authorization process, but it does not eliminate all testing requirements. The medical device manufacturer is still responsible for:
- EMC testing of the complete device (the module's certification does not cover the host device)
- Wireless coexistence testing in the context of the medical device
- Cybersecurity assessment of the complete wireless system
- Risk management addressing wireless-specific hazards
Do I need separate FCC authorization for each medical device model?
It depends. If different device models use the same radio module in the same configuration (same antenna, same enclosure, same power supply), a single FCC certification may cover multiple models. However, if the antenna, enclosure, or power supply changes, additional testing and possibly a new certification may be required. Consult your TCB for guidance.
How does the EU MDR interact with RED for wireless medical devices?
They are separate legal frameworks with overlapping technical requirements. The EU MDR addresses safety and performance of the medical device; the RED addresses radio spectrum efficiency and safety of the radio equipment. A wireless medical device must comply with both. In practice, the EMC testing conducted for EU MDR (to IEC 60601-1-2) can often be leveraged for RED compliance (to EN 301 489), but additional RF-specific tests are always required.
What if my device uses only Wi-Fi or Bluetooth?
Even common wireless technologies like Wi-Fi and Bluetooth require formal compliance. For the US, this means FCC SDoC or Certification under Part 15. For the EU, this means RED compliance per ETSI EN 300 328 (Wi-Fi) or ETSI EN 300 440 (Bluetooth). The medical device risk management must also address the specific risks of the chosen wireless technology — including signal loss, interference, and data security.
When should I start wireless compliance planning?
At the beginning of device development — not after. Wireless compliance requirements influence hardware design (antenna placement, RF shielding, power supply design), software architecture (security protocols, error handling), and risk management (wireless-specific hazards). Retrofitting wireless compliance late in development is expensive and often requires hardware redesign.